What is the Supriya Lifescience Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 6.44% of the total equity shares of Supriya Lifescience Ltd.

What is the Supriya Lifescience Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 5.47% of the total equity shares of Supriya Lifescience Ltd.

How has the Supriya Lifescience Ltd promoter holding changed?

The promoter holding in Supriya Lifescience Ltd changed from 68.30% to 68.30% during the latest reported period.

How has the Supriya Lifescience Ltd FII holding changed?

The FII holding in Supriya Lifescience Ltd changed from 6.19% to 6.44% during the latest reported period.

How has the Supriya Lifescience Ltd DII holding changed?

The DII holding in Supriya Lifescience Ltd changed from 5.30% to 5.47% during the latest reported period.

Who are the major shareholders of Supriya Lifescience Ltd?

The major shareholders of Supriya Lifescience Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Supriya Lifescience Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Supriya Lifescience Ltd public shareholding?

Public shareholders hold 19.79% of the total equity shares of Supriya Lifescience Ltd as per the latest available data.

Supriya Lifescience Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE

₹818.55

-17.70(-2.12%)

As on 23 Oct 2026 at 15:59

As of 23 Oct 2026 at 15:59, Supriya Lifescience Ltd is trading at ₹818.55. The 52-week range stands at ₹545.50–₹1,085.00, with a market cap of ₹6.59 thousand crore. At a P/E of 33.17 and a dividend yield of 0.12%, it is a mid-cap stock in the Pharmaceuticals sector.